Episode: 039: Reflections on Our Interview with Dr. Julie Holland


Entheogen Logo
Subscribe
039: Reflections on Our Interview with Dr. Julie Holland

This is Entheogen. Talk about tools for generating the divine within.

Today is July 20, 2016, and we are reflecting on our interview with Dr. Julie Holland from last season.

Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook. Thanks for listening.

 

Your pledges make the show possible! We're trying to cover expenses by asking our fans to pledge at Patreon.com/Entheogen. We really appreciate your support!

Topics:



Entheogen
Users who viewed this episode also viewed...

Entheogen > 038: Interview with Alasdair from Bluelight.org

This is Entheogen. Talk about tools for generating the divine within. Today is December 4, 2016, and we are talking with Alisdair from BlueLight.org. Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook...

Entheogen > 035: MAPS to Move Ahead with Phase 3 MDMA Trials

F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients – NY Times, Nov 29, 2016 “It changed my life.” It allowed me to see my trauma without fear or hesitation and finally process things and move forward." – study participant Ed Thompson “There is now a clear path ahead to make MDMA a legal medicine for millions of people suffering from PTSD...

Entheogen > 043: The LSD-assisted Dock Ellis No-Hitter

This is Entheogen. Elevate the Conversation.   Please support Entheogen by making a donation on Patreon. Become a Patron for as little as $1. Pledge just $3 or more, and get early access to new episodes, plus exclusive Patron-only features. Head over to EntheogenShow.com and click on Support. Find the notes and links for this and other episodes at EntheogenShow...
Comments (0)

Login or Sign up to leave a comment.

Log in
Sign up

Be the first to comment.